GJB2 and nodular sclerosis classical Hodgkin lymphoma: The GJB2 c.−23+1G>A splice site mutation was reported as a significant contributor to NSHL (up to 5%) in many European countries [4] and in the Hungarian cohorts (3.1%) [10].